Submicroscopic parasitemia |
What proportion of untreated/unrecognized submicroscopic infections persist asymptomatically? |
Retrospective molecular analysis of prior cohort studies where only microscopy was used. |
What proportion go on to become microscopically patent and/or symptomatic? |
How often do treated patients develop subsequent submicroscopic parasitemia? |
Retrospective molecular analysis of therapeutic efficacy studies. |
Transmission potential of submicroscopic infections |
What proportion of submicroscopic infections harbor or produce gametocytes, and at what density? |
Prospective molecular analysis incorporated into cohort studies or national surveys. |
Besides gametocyte density, what parasite or human host factors affect human-to-mosquito infectivity? |
In vitro membrane feeding assays |
How commonly does submicroscopic vs. microscopic malaria in asymptomatics successfully infect mosquitoes? How does this vary in different transmission settings and in different mosquito vectors? |
Vectorial capacity studies, estimates of Entomological Inoculation Rate (EIR), mosquito membrane feeding studies in vitro and from patients in surveys and/or cohorts |
Diagnostic tests to detect submicroscopic parasitemia and estimate transmissibility |
How sensitive does a diagnostic test need to be to identify all those in the infectious reservoir? |
Comparative analysis of diagnostic tests incorporated into cohort studies and mass surveys, paired with malaria seroprevalence surveys |
How large is the hypnozoite reservoir in P. vivax endemic areas, and how can it be measured? |
Studies to identify surrogate markers of latent P. vivax infection |